News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,381 Results
Type
Article (14182)
Company Profile (282)
Press Release (251917)
Section
Business (79495)
Career Advice (153)
Deals (13224)
Drug Delivery (35)
Drug Development (50437)
Employer Resources (31)
FDA (5712)
Job Trends (5127)
News (144370)
Policy (10028)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (910)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21632)
ALS (60)
Alzheimer's disease (824)
Antibody-drug conjugate (ADC) (86)
Approvals (5727)
Artificial intelligence (107)
Autoimmune disease (10)
Automation (5)
Bankruptcy (104)
Best Places to Work (4560)
BIOSECURE Act (5)
Biosimilars (39)
Biotechnology (232)
Bladder cancer (43)
Brain cancer (19)
Breast cancer (139)
Cancer (1280)
Cardiovascular disease (100)
Career advice (132)
Career pathing (2)
CAR-T (107)
Cell therapy (304)
Cervical cancer (7)
Clinical research (40849)
Collaboration (495)
Compensation (218)
Complete response letters (13)
COVID-19 (1034)
CRISPR (36)
C-suite (141)
Cystic fibrosis (76)
Data (1331)
Denatured (11)
Depression (28)
Diabetes (122)
Diagnostics (1291)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (76)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (81)
Earnings (29626)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (48091)
Executive appointments (396)
FDA (6324)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (462)
Gene editing (87)
Generative AI (9)
Gene therapy (226)
GLP-1 (353)
Government (1074)
Grass and pollen (2)
Guidances (18)
Healthcare (6586)
Huntington's disease (21)
IgA nephropathy (20)
Immunology and inflammation (78)
Indications (18)
Infectious disease (1096)
Inflammatory bowel disease (110)
Inflation Reduction Act (8)
Influenza (18)
Intellectual property (55)
Interviews (17)
IPO (7261)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (200)
Leadership (2)
Legal (1386)
Liver cancer (30)
Lung cancer (184)
Lymphoma (81)
Machine learning (1)
Management (7)
Manufacturing (114)
MASH (47)
Medical device (2587)
Medtech (2588)
Mergers & acquisitions (6249)
Metabolic disorders (359)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (57)
Neuropsychiatric disorders (23)
Neuroscience (1187)
NextGen: Class of 2025 (2016)
Non-profit (852)
Northern California (1528)
Now hiring (21)
Obesity (184)
Opinion (100)
Ovarian cancer (59)
Pain (40)
Pancreatic cancer (51)
Parkinson's disease (104)
Partnered (6)
Patents (109)
Patient recruitment (66)
Peanut (35)
People (25485)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14421)
Phase II (19006)
Phase III (12013)
Pipeline (678)
Podcasts (46)
Policy (35)
Postmarket research (852)
Preclinical (6059)
Press Release (30)
Prostate cancer (52)
Psychedelics (35)
Radiopharmaceuticals (211)
Rare diseases (270)
Real estate (1414)
Recruiting (12)
Regulatory (8548)
Reports (15)
Research institute (936)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (2)
RSV (10)
Schizophrenia (54)
Series A (91)
Series B (59)
Service/supplier (1)
Sickle cell disease (37)
Southern California (1356)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (1971)
State (1)
Stomach cancer (4)
Supply chain (18)
The Weekly (33)
United States (11971)
Vaccines (204)
Venture capitalists (28)
Webinars (7)
Weight loss (105)
Women's health (15)
Worklife (2)
Date
Today (81)
Last 7 days (359)
Last 30 days (1603)
Last 365 days (19959)
2025 (4559)
2024 (20552)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (38)
Alaska (2)
Arizona (52)
Arkansas (5)
Asia (17207)
Australia (2915)
California (3479)
Canada (1044)
China (319)
Colorado (135)
Connecticut (143)
Delaware (87)
Europe (37006)
Florida (408)
Georgia (106)
Idaho (16)
Illinois (209)
India (8)
Indiana (85)
Iowa (1)
Japan (68)
Kansas (59)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (441)
Massachusetts (2738)
Michigan (69)
Minnesota (134)
Mississippi (1)
Missouri (22)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (14)
New Jersey (871)
New Mexico (12)
New York (949)
North Carolina (516)
North Dakota (4)
Northern California (1528)
Ohio (107)
Oklahoma (9)
Oregon (21)
Pennsylvania (663)
Puerto Rico (3)
Rhode Island (15)
South America (208)
South Carolina (4)
Southern California (1356)
Tennessee (25)
Texas (397)
Utah (48)
Virginia (67)
Washington D.C. (28)
Washington State (316)
Wisconsin (13)
266,381 Results for "appili therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update
March 18, 2025
·
8 min read
Press Releases
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025
February 17, 2025
·
9 min read
Business
Appili Therapeutics Reports Fiscal Year 2024 Financial and Operational Results
Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced its financial and operational results for the fiscal year ended March 31, 2024 (“FYE 2024”), and provided an update on the Company’s strategy for fiscal 2025.
June 25, 2024
·
10 min read
Press Releases
Aditxt’s Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appili’s Shareholder Approval
October 10, 2024
·
8 min read
Press Releases
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
November 15, 2024
·
9 min read
Press Releases
Aditxt’s Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders
November 7, 2024
·
4 min read
Business
Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
September 17, 2024
·
2 min read
Press Releases
Appili Therapeutics Presents Update on ATI-1701 Biodefense Vaccine Candidate at IDWeek™ 2024
October 17, 2024
·
5 min read
Press Releases
Appili Therapeutics Announces Mailing of the Management Information Circular in Connection with the Special Meeting of Shareholders
October 10, 2024
·
10 min read
Press Releases
Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
November 1, 2024
·
6 min read
1 of 26,639
Next
